At a glance
- Originator Goteborg University
- Developer Goteborg University; Pharmacia Corporation
- Class
- Mechanism of Action Dopamine D2 receptor antagonists; Dopamine D3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 04 Feb 1997 No-Development-Reported for Psychotic disorders in Sweden (Unknown route)
- 04 Feb 1997 No-Development-Reported for Psychotic disorders in USA (Unknown route)